Microporous macrocapsules

• US 5,955,095 A
• Filed: 08/14/1995
• Issued: 09/21/1999
• Est. Priority Date: 04/22/1992
• Status: Expired due to Term

• Current Assignee: Neurotech S.A. (LivaNova Plc)
• Original Assignee: Brown University
• Inventors: Flanagan, Thomas, Rein, David, Doherty, Edward J., Tresco, Patrick A., Gentile, Frank T., Hazlett, Tyrone, Holland, Laura M.
• Primary Examiner(s): LANE, SALLY GARDNER
• Application Number:
  US08/436,281
• Time in Patent Office: 1,499 Days
• Field of Search: 424/422, 424/451, 424/462, 424/424, 424/520
• US Class Current: 424/422
• CPC Class Codes: A61K 9/4816 Wall or shell material

Abstract

Microporous macrocapsules are disclosed which are useful as implantation devices for cell therapy. The macrocapsule comprises living cells that secrete biological substance that are therapeutically useful and that are released from the macrocapsule to the site of implantation. The capsules can have selected permeability characteristics based upon their particular usage and desired viral retentivity characteristics.

Claims

1. An implantable permselective device for use in cell therapy comprising:

(a) a core comprising living cells that are capable of secreting a selected biologically active product or of providing a selected biological function; and

(b) an external jacket surrounding said core, said jacket comprising a biocompatible material substantially free of said cells, said jacket having a nominal molecular weight cutoff greater than about 440 kD;

said core and said jacket forming a macrocapsule, which device is substantially non-immunoisolatory.

2. The permselective device of claim 1 wherein said core additionally comprises a hydrogel matrix, said living cells being immobilized by said matrix.

3. The permselective device of claim 1 wherein said biocompatible material is comprised of hydrogels.

4. The permselective device of claim 2 wherein said core and said biocompatible materials are comprised of the same hydrogel.

5. The permselective device of claim 1 wherein said biocompatible material comprises alginate cross-linked with a multivalent ion.

6. The permselective device of claim 1 wherein said biocompatible material comprises a thermoplastic membrane.

7. The permselective device of claim 1 wherein the said nominal molecular weight cutoff is between about 1,000 to about 3,000 kD.

8. The permselective device of claim 1 wherein said external jacket has a nominal molecular weight cutoff below the molecular weight of detrimental viruses which may be shed from said living cells.

9. The permselective device of claim 1 wherein said living cells have been genetically modified with a virus, and said nominal molecular weight cutoff is below the molecular weight of said virus.

10. The permselective device of claim 9 wherein said external jacket has a viral retentivity value of less than about 10².

11. The permselective device of claim 1 further comprising:

(c) a tether for the retrieval of said device.

12. The permselective device of claim 1 wherein said core additionally comprises immunoisolatory devices in which said living cells are encapsulated.

13. The permselective device of claim 12 wherein said immunoisolatory devices are selected from the group consisting of microspheres and alginate noodles.

14. An implantable device for providing a therapeutically useful product to a recipient, the device comprising:

(a) a core comprising a polymeric implant that is capable of secreting a selected therapeutically useful product, and

(b) an external jacket surrounding said core formed of a biocompatible material, said jacket having a nominal molecular weight cutoff greater than about 440 kD;

said core and said jacket forming a macrocapsule, which macrocapsule is substantially non-immunoisolatory.

15. A method of cell therapy comprising implanting a permselective device into the body of a recipient, said device comprising:

(a) a core comprising living cells that are capable of secreting a selected biologically active product or of providing a selected biological function; and

(b) an external jacket surrounding said core, said jacket comprising a biocompatible material substantially free of said cells, said jacket having a nominal molecular weight cutoff greater than about 440 kD;

said core and said jacket forming a macrocapsule, which macrocapsule is substantially non-immunoisolatory.

16. The method of claim 15 wherein said external jacket has a molecular weight cutoff below the molecular weight of detrimental viruses which may be shed from said living cells.

17. The method of claim 15 wherein said living cells have been genetically modified with a virus, and said nominal molecular weight cutoff is below the molecular weight of said virus.

18. The method of claim 17 wherein said external jacket has a Viral retentivity value of less than about 10².

19. The method of claim 15 wherein said permselective device further comprises:

(c) a tether for the retrieval of said macrocapsule, and said method comprises the additional step of retrieving said macrocapsule at the termination of said therapy.